跳至主要内容
临床试验/EUCTR2013-002026-22-NL
EUCTR2013-002026-22-NL进行中(未招募)不适用

Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia.A pharmacodynamic and pharmacokinetic study - NEOPREMEC

ErasmusMC0 个研究点开始时间: 2013年6月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age ± 6 weeks and weight > 3 kg
  • Pathologic GERD, diagnosed by criteria stated in paragraph 2.3 --> pathologic GERD related to esophageal atresia or congenital hernia Diaphragmatica
  • Written Informed consent by both parents
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 20
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known hypersensitivity to omeprazole
  • Co-medication (or changes to prohibited comedication during the trial): alprazolam, midazolam, triazolam, carbamazepine, clorazepate, ciclosporine, disulfiram, fenytoïne, ferrous components, itraconazole, ketoconazole, voriconazole, methotrexate, tacrolimus, ticlopidine, warfarine
  • Patients with GERD caused by congentital malformations of the CNS

研究者

发起方
ErasmusMC

相似试验